Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study.

Proctor SJ, Wilkinson J, Jones G, Watson GC, Lucraft HH, Mainou-Fowler T, Culligan D, Galloway MJ, Wood KM, McNally RJ, James PW, Goodlad JR.

Blood. 2012 Jun 21;119(25):6005-15. doi: 10.1182/blood-2011-12-396556. Epub 2012 May 10.

PMID:
22577177
[PubMed - indexed for MEDLINE]
Free Article
2.

Progress in the prognosis of adult Hodgkin's lymphoma in the past 35 years through clinical trials in Argentina: a GATLA experience.

Pavlovsky S, Lastiri F.

Clin Lymphoma. 2004 Sep;5(2):102-9.

PMID:
15453925
[PubMed - indexed for MEDLINE]
3.

[Treatment results of Hodgkin's lymphoma].

Aleknavicius E, Valuckas KP, Aleknaviciene B, Norkiene L, Smailyte G.

Medicina (Kaunas). 2009;45(8):615-23. Lithuanian.

PMID:
19773620
[PubMed - indexed for MEDLINE]
Free Article
4.

Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution.

Frata P, Buglione M, Grisanti S, Bonetti B, Vitali E, De Stefani A, Magri E, Peveri A, Marini G, Rossi G, Magrini SM.

Tumori. 2005 Nov-Dec;91(6):456-62.

PMID:
16457141
[PubMed - indexed for MEDLINE]
5.

Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.

Liao Z, Ha CS, Vlachaki MT, Hagemeister F, Cabanillas F, Hess M, Tucker S, Cox JD.

Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):971-7.

PMID:
11429225
[PubMed - indexed for MEDLINE]
6.

Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.

Sénécal D, Jais JP, Desablens B, Berthou C, Casassus P, Moles MP, Delwail V, Gastinne T, Colonna P, Andrieu JM.

Cancer. 2008 Feb 15;112(4):846-55.

PMID:
18072259
[PubMed - indexed for MEDLINE]
Free Article
7.

Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experience.

Pectasides D, Economopoulos T, Kouvatseas G, Antoniou A, Zoumbos Z, Aravantinos G, Tsatalas C, Halikia A, Nikolaides C, Kiamouris C, Pappa E, Pavlidis N, Skarlos D, Fountzilas G, Dimopoulos MA.

Oncology. 2000 May;58(4):286-92.

PMID:
10838493
[PubMed - indexed for MEDLINE]
8.

Prognostic factors of Hodgkin's lymphoma and their impact on response to chemotherapy and survival.

Abdel Hamid TM, El Zawahry HM, Khattab NA, Mowafy TM, Awaad MM, Ali El-Din NH, Mokhtar NM.

J Egypt Natl Canc Inst. 2005 Mar;17(1):9-14.

PMID:
16353077
[PubMed - indexed for MEDLINE]
Free Article
9.

A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.

Somers R, Carde P, Henry-Amar M, Tarayre M, Thomas J, Hagenbeek A, Monconduit M, de Pauw BE, Breed WP, Verdonck L, et al.

J Clin Oncol. 1994 Feb;12(2):279-87.

PMID:
7509381
[PubMed - indexed for MEDLINE]
10.

Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.

Savage KJ, Al-Rajhi N, Voss N, Paltiel C, Klasa R, Gascoyne RD, Connors JM.

Ann Oncol. 2006 Jan;17(1):123-30. Epub 2005 Oct 19.

PMID:
16236753
[PubMed - indexed for MEDLINE]
Free Article
11.

Localized non-Hodgkin's lymphoma of Waldeyer's ring: clinical features, management, and prognosis of 130 adult patients.

Ezzat AA, Ibrahim EM, El Weshi AN, Khafaga YM, AlJurf M, Martin JM, Ajarim DS, Bazarbashi SN, Stuart RK, Zucca E.

Head Neck. 2001 Jul;23(7):547-58.

PMID:
11400243
[PubMed - indexed for MEDLINE]
12.

Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL).

Won YW, Kwon JH, Lee SI, Oh SY, Kim WS, Kim SJ, Won JH, Kim KH, Park SK, Kim JS, Suh C, Yoon DH, Park JS, Kim MK, Kim H, Kang HJ, Mun YC, Kwak JY, Kim HJ, Eom HS.

Ann Hematol. 2012 Feb;91(2):223-33. doi: 10.1007/s00277-011-1297-x. Epub 2011 Jul 26.

PMID:
21789622
[PubMed - indexed for MEDLINE]
13.

Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality.

Cheung MM, Chan JK, Lau WH, Ngan RK, Foo WW.

Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):182-90.

PMID:
12182990
[PubMed - indexed for MEDLINE]
14.

Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin's Disease treated with chemotherapy.

Montalban C, Abraira V, Morente M, Acevedo A, Aguilera B, Bellas C, Fraga M, Del Moral RG, Menarguez J, Oliva H, Sanchez-Beato M, Piris MA.

Leuk Lymphoma. 2000 Nov;39(5-6):563-72.

PMID:
11342339
[PubMed - indexed for MEDLINE]
15.

Long-term outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma.

Sirohi B, Cunningham D, Powles R, Murphy F, Arkenau T, Norman A, Oates J, Wotherspoon A, Horwich A.

Ann Oncol. 2008 Jul;19(7):1312-9. doi: 10.1093/annonc/mdn052. Epub 2008 Mar 19.

PMID:
18356139
[PubMed - indexed for MEDLINE]
Free Article
16.

Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience.

Viviani S, Di Nicola M, Bonfante V, Di Stasi A, Carlo-Stella C, Matteucci P, Magni M, Devizzi L, Valagussa P, Gianni AM.

Leuk Lymphoma. 2010 Jul;51(7):1251-9. doi: 10.3109/10428194.2010.486090.

PMID:
20528244
[PubMed - indexed for MEDLINE]
17.

Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.

Salvagno L, Sorarù M, Sotti G, Aversa S, Chiarion Sileni V, Mazzarotto R, Scarzello G, Bianco A, Pappagallo GL, Fiorentino MV.

Ann Oncol. 1995 Feb;6(2):173-9.

PMID:
7540419
[PubMed - indexed for MEDLINE]
18.

Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up.

Chen RC, Chin MS, Ng AK, Feng Y, Neuberg D, Silver B, Pinkus GS, Stevenson MA, Mauch PM.

J Clin Oncol. 2010 Jan 1;28(1):136-41. doi: 10.1200/JCO.2009.24.0945. Epub 2009 Nov 23.

PMID:
19933914
[PubMed - indexed for MEDLINE]
Free Article
19.

An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.

Chronowski GM, Wilder RB, Tucker SL, Ha CS, Sarris AH, Hagemeister FB, Barista I, Hess MA, Cabanillas F, Cox JD.

Cancer. 2002 Dec 15;95(12):2534-8.

PMID:
12467067
[PubMed - indexed for MEDLINE]
Free Article
20.

High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only.

van Grotel M, Lam KH, de Man R, Beishuizen A, Pieters R, van den Heuvel-Eibrink MM.

Leuk Lymphoma. 2006 Aug;47(8):1504-10.

PMID:
16966260
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk